• Sviatoslav Semenenko Pirogov National Memorial Medical University
  • Andrii Semenenko Pirogov National Memorial Medical University
Keywords: traumatic brain injury, amantadine sulfate, rats


The development and introduction into practice of emergency neurology of new drugs capable of influencing secondary neuronal damage in patients with traumatic brain injury (TBI) has made a significant impact on the recovery of such patients.

Aim of the work was to evaluate the magnitude of cerebroprotective action of amantadine sulfate in terms of impaired carbohydrate metabolism of the brain against the background of experimental TBI.

Materials and methods. The experimental model of severe TBI was caused by the action of a carbon dioxide flow under pressure, which was created using a gas balloon of pneumatic gun. The therapeutic effect of amantadine sulfate on TBI model was evaluated with a 5 mg/kg dose. The pseudo-operated animals and control group received 0.9 % NaCl solution at a dose of 2 ml/kg with IV administration.

Results. The obtained results confirm the formation of a hypo-energetic state in the brain cells of rats on the background of TBI, which is probably a consequence of the suppression of the processes of oxidative phosphorylation and its conjugation with tissue respiration. TBI is accompanied by activation of anaerobic glycolysis and inhibition of aerobic glucose oxidation, proving that there is an imbalance between the levels of lactate and pyruvate intermediates. 8-day infusion of rats with traumatic brain injury of amantadine sulfate, inhibited anaerobic glycolysis hyperactivation, stimulated tissue respiration processes, reduced signs of lactic acidosis and development of secondary alteration of brain cells by non-oxidized products.

Conclusions. In the course of the experiment, it was found that the treatment of rats, with TBI model, with 0.9 % NaCl solution did not significantly contribute to the restoration of impaired energy metabolism (p<0.05) and did not reduce the manifestation of metabolic acidosis in the damaged brain (p<0.05). The use of amantadine sulphate in TBI rats significantly corrects carbohydrate metabolism disorders than 0.9 % NaCl solution and contributes to the reduction of metabolic acidosis in the damaged brain (p<0.05).


Download data is not yet available.

Author Biographies

Sviatoslav Semenenko, Pirogov National Memorial Medical University

PhD, Associate professor

Department of Clinical Pharmacy and Clinical Pharmacology

Andrii Semenenko, Pirogov National Memorial Medical University

MD, Professor

Department of Anesthesiology, Intensive Care and Emergency Medicine


Arun, P., Ariyannur, P. S., Moffett, J. R., Xing, G., Hamilton, K., Grunberg, N. E. et. al. (2010). Metabolic Acetate Therapy for the Treatment of Traumatic Brain Injury. Journal of Neurotrauma, 27 (1), 293–298. doi: http://doi.org/10.1089/neu.2009.0994

Semenenko, A. I., Kobelyatskyi, Y. Y., Kondratskyi, B. А., Semenenko, N. A. (2016). Evaluation of the Therapeutice Fficacy of 0.9 % NaCl Solution and the Solution of Mannitol in Patients with Acute Ischemic Stroke by Neurologic Deficit. Emergency medicine, 6 (77), 98–101. doi: http://doi.org/10.22141/2224-0586.6.77.2016.82174

Saniova, B., Drobny, M., Lehotsky, J., Sulaj, M., Schudichova, J. (2006). Biochemical and Clinical Improvement of Cytotoxic State by Amantadine Sulphate. Cellular and Molecular Neurobiology, 26 (7-8), 1473–1480. doi: http://doi.org/10.1007/s10571-006-9033-0

Khodakivskyi, O. A. (2013). Vplyv ademolu na pokaznyky enerhetychnoho obminu v holovnomu mozku shchuriv iz modelliu hostroi tserebralnoi ishemii. Bukovynskyi medychnyi visnyk, 2 (66), 140–143.

Oddo, M., Poole, D., Helbok, R., Meyfroidt, G., Stocchetti, N., Bouzat, P. et. al. (2018). Fluid therapy in neurointensive care patients: ESICM consensus and clinical practice recommendations. Intensive Care Medicine, 44 (4), 449–463. doi: http://doi.org/10.1007/s00134-018-5086-z

Han, J., Yang, F., Jiang, W., Zhang, G., Liu, Z., Liu, X. et. al. (2012). Hydroxyethyl starch 130/0.4 and sodium chloride injection as adjunctive therapy in patients with cerebral hypoperfusion. BMC Neurology, 12 (1), 127–135. doi: http://doi.org/10.1186/1471-2377-12-127

Lehmann, L., Bendel, S., Uehlinger, D. E., Takala, J., Schafer, M., Reinert, M., Jakob, S. M. (2012). Randomized, Double-Blind Trial of the Effect of Fluid Composition on Electrolyte, Acid–Base, and Fluid Homeostasis in Patients Early After Subarachnoid Hemorrhage. Neurocritical Care, 18 (1), 5–12. doi: http://doi.org/10.1007/s12028-012-9764-3

Cemenenko, A. I. (2013). Dynamika aktyvnosti neiron-spetsyfichnoi enolazy ta vmistu bilka S 100 u krovi shchuriv za umov hostroho porushennia mozkovoho krovoobihu ta kursovoho vvedennia 0,9 % rozchynu NaCl. Farmakolohiia ta likarska toksykolohiia, 6 (36), 9–13

Prokhorova, M. I. (1982). Sovremennye metody biokhimicheskikh issledovanii. Leningrad: Iz-vo Leningradskogo un-ta, 272.

Elkon, B., Cambrin, J. R., Hirshberg, E., Bratton, S. L. (2014). Hyperglycemia: an independent risk factor for poor outcome in children with traumatic brain injury. Pediatric Critical Care Medicine, 15 (7), 623–631. doi: http://doi.org/10.1097/pcc.0000000000000170

Peffer, J., McLaughlin, C. (2013). The correlation of early hyperglycemia with outcomes in adult trauma patients: a systematic review. J Spec Oper Med, 13 (4), 34–39.

👁 172
⬇ 167
How to Cite
Semenenko, S., & Semenenko, A. (2019). EFFECTIVENESS OF CORRECTION OF DISCUSSION OF CARBOHYDRATE METABOLISM IN RATS WITH CRANIOCEREBRAL INJURY. Technology Transfer: Innovative Solutions in Medicine, 30-32. https://doi.org/10.21303/2585-663.2019.001069
Medicine and Dentistry